New York · Sector coverage
Healthcare & Life Sciences in New York.
US healthcare's capital markets — from biotech listings to payer consolidation — concentrate in New York; the firm's coverage develops with its disclosed record.
How the firm covers healthcare in New York at the intersection of blockchain, artificial intelligence, automation, quantum security, and data infrastructure is set out below, with the operating registers linked throughout.
The technology angles
Blockchain in New York healthcare
Health data's problem is trust between institutions that compete: verifiable credentials, consent registries, and pharmaceutical supply-chain provenance are the blockchain use-cases that survive diligence.
AI and agents in New York healthcare
Agents attack the administrative half of medicine — documentation, prior authorization, claims — while clinical judgment stays human. Measurable outcomes in denials, receivable days, and documentation time make it the rare AI market with CFO-legible returns.
Automation and robotics in New York healthcare
Lab automation, pharmacy robotics, and hospital logistics — the physical workflows where healthcare's labor shortage meets its safety case.
Quantum and security in New York healthcare
Genomic and patient records are decades-long secrets — the exact profile post-quantum cryptography exists to protect — while quantum simulation is a live frontier in drug discovery. Both ends of the sector touch the technology.
Data and compute infrastructure in New York healthcare
Health data infrastructure — interoperability rails, imaging pipelines, federated research networks — is the substrate every clinical AI application depends on; coverage treats it as the sector's picks and shovels.
The New York platform
Investment Banking
US financings, cross-border M&A, and US exchange listings.
Public Equity
US-listed positions and institutional investor engagement.
Debt Capital
Placement with US institutional credit.